ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,793.30
1.44%
S&P ASX All Technology
3,068.10
1.62%
Brent Oil
83.085
-0.47%
US Dollar vs AUD
1.51586
0.40%
Bitcoin
63,022.76
-0.19%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kinnate Biopharma Inc (KNTE)

  7. Kinnate Biopharma Inc (KNTE) News

KNTE Kinnate Biopharma Inc

2.65
0.00 (0.00%)
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Kinnate Biopharma Inc KNTE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.65 10:00:00
Open Price Low Price High Price Close Price Previous Close
2.65
more quote information »

Recent News

Date Time Source Heading
04/4/202400:00GLOBEXOMA Corporation Announces Closing of Tender Offer
20/3/202407:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
06/3/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:27EDGAR2Form SC 14D9 - Solicitation, recommendation statements
02/3/202400:53EDGAR2Form SC14D9C - Written communication relating to third party..
02/3/202400:50EDGAR2Form 8-K - Current report
02/3/202400:35PRNUSKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
02/3/202400:30GLOBEKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
21/2/202422:01EDGAR2Form SC14D9C - Written communication relating to third party..
17/2/202409:57PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
17/2/202402:46PRNUSKuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to..
17/2/202401:10EDGAR2Form 8-K - Current report
17/2/202400:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
15/2/202401:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202408:05EDGAR2Form 8-K - Current report
06/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202301:00EDGAR2Form 8-K - Current report
10/11/202308:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:14EDGAR2Form 8-K - Current report
10/11/202308:05GLOBEKinnate Biopharma Inc. Reports Third Quarter 2023 Financial..
19/9/202306:28EDGAR2Form 8-K - Current report
19/9/202306:10GLOBEKinnate Biopharma Inc. Announces Pipeline Updates, Strategic..
07/9/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202306:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:16EDGAR2Form 8-K - Current report
09/8/202306:05GLOBEKinnate Biopharma Inc. Reports Second Quarter 2023 Financial..
29/7/202306:06EDGAR2Form 8-K - Current report
02/6/202306:05GLOBEKinnate Biopharma Inc. to Participate in Upcoming Investor..
12/5/202306:05GLOBEKinnate Biopharma Inc. Reports First Quarter 2023 Financial..

Your Recent History

NASDAQ
KNTE
Kinnate Biopharma
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved